November 2026 · updated monthly

All Roles × Health Insurance & Payer: How the Conversation Is Moving

Topic sentiment, reach, and momentum for Health Insurance & Payer leaders, measured from real executive-interview podcasts. Biggest recent move: Innovation (+1.5 vs. quarter ago).

How we build the index

Topic Indexes — Health & Life Sciences

147 episodes in the trailing window

50 = neutral baseline. Scores above 50 read net-optimistic, below 50 net-pessimistic; reach amplifies the swing. Thin segments roll up to their parent group.

In their own words — Health & Life Sciences

Representative takes behind each index, drawn verbatim from executive interviews.

What do Health & Life Sciences leaders say about the future in November 2026?

Across 147 executive interviews, Future Outlook sentiment reads 76.5/100 — net-optimistic, up 1.3 vs. quarter ago. Here's the range of what they're actually saying:

  • BullishHost is hopeful about outcomes: 'It will get done if somebody owns it,' and 'you'll start seeing that it's getting done,' pointing to a dependable team ahead.

    Dental Practice Heroes — You've Got Unscheduled Treatment. So Why Is Your Schedule Empty? · Nov 2026

  • MixedGuest's own forward-looking mood is not really expressed; he looks ahead mainly to needing 'better studies' before endorsing maropitant for analgesia, which is measured rather than optimistic or pessimistic.

    The Cone of Shame Veterinary Podcast — 424 - Does Maropitant Really Reduce Surgical Pain? · Oct 2026

  • SkepticalGuests see continued real-terms Medicare cuts (Ketchum: 35% below 2016, "continual reductions") and warn of attrition and burnout, though Chernu says it is not a "burning platform" right now.

    Off the Chart: A Business of Medicine Podcast — S1 Ep198: Medicare’s 2027 fee schedule won’t settle the physician pay debate, with four health policy experts · Oct 2026

What do Health & Life Sciences leaders say about the economy in November 2026?

Across 147 executive interviews, Economy sentiment reads 42.5/100 — net-cautious, down 1.0 vs. quarter ago. Here's the range of what they're actually saying:

  • BullishMacro discussion is brief, but the hosts frame inflation as favorable ('inflation takes care of you' as an asset owner) and see debt and leverage as advantageous.

    Bulletproof Dental Practice — Associate to Owner: Burn the Boats · Sep 2026

  • MixedBroader economy is mostly historical and neutral (Great Recession lending defaults, banks tightening underwriting), with only mild concern about rising expenses against flat PPO reimbursement.

    The Thriving Dentist Show — What Is Your Dental Practice Really Worth? · Oct 2026

  • SkepticalGuest cites rising interest rates, tight credit markets, and Wall Street Journal headlines about failed DSOs as reasons the recap collapsed, a negative read on the external funding climate, softened only by 'they've actually improved a…

    The Dentalpreneur Podcast w/ Dr. Mark Costes — 2631: Looking Beyond the Valuation in a Practice Partnership · Nov 2026

What do Health & Life Sciences leaders say about their industry in November 2026?

Across 147 executive interviews, Industry Forecast sentiment reads 51.0/100 — a mixed read, down 1.2 vs. quarter ago. Here's the range of what they're actually saying:

  • BullishGuest sees whitening growing in dental and orthodontic practices, noting 'we're seeing a lot of growth' as personalized trays make add-on whitening easy to offer.

    The DSO Hygienist with Christine Diehl — The Business of Brighter Smiles Making Teeth Whitening Work for Your Practice · Nov 2026

  • MixedMixed outlook for healthcare: expects AI cost savings in administration and job displacement, plus a growing patchwork of state privacy laws and a "race to upcode," balanced by the view that doing it right creates a competitive moat.

    The Big Unlock — Episode 233 – In the Age of AI, Healthcare Privacy Goes Beyond HIPAA · Nov 2026

  • SkepticalHe says "the floor has changed in dentistry" and that owners today often make the same or less than associates, so there is less margin for mediocre acquisitions, though strong practices remain attainable.

    Shared Practices | Your Dental Roadmap through Practice Ownership — Why Your CPA Will Talk You Out of a Great Dental Practice · Nov 2026

What do Health & Life Sciences leaders say about AI in November 2026?

Across 147 executive interviews, AI sentiment reads 59.4/100 — net-optimistic, up 1.2 vs. quarter ago. Here's the range of what they're actually saying:

  • BullishGuest views AI as a real trend that can deliver realistic previews and patient education, saying 'the AI is very much involved' and that Global Dent is in talks with AI companies.

    The DSO Hygienist with Christine Diehl — The Business of Brighter Smiles Making Teeth Whitening Work for Your Practice · Nov 2026

  • MixedBalanced: praises AI savings, oral consent for ambient scribes, and the need to meet patients where they are, but flags hallucinations, easier re-identification, and chatbots falsely claiming to be licensed therapists.

    The Big Unlock — Episode 233 – In the Age of AI, Healthcare Privacy Goes Beyond HIPAA · Nov 2026

  • SkepticalSkeptical of general AI for this task ('ChatGPT can't reliably solve this problem' and uploading patient reports to it is a HIPAA breach), though he describes his firm's own guarded AI use positively.

    The Dental Marketer — Why Trusting Reports Can Cost Dentists Six Figures | David Harris | 631 · Oct 2026

What do Health & Life Sciences leaders say about innovation in November 2026?

Across 147 executive interviews, Innovation sentiment reads 71.3/100 — net-optimistic, up 1.5 vs. quarter ago. Here's the range of what they're actually saying:

  • BullishGuest is positive about technology advances such as scanners and personalized trays, and about new product lines, though he downplays the value of accelerator lights in favor of the gel.

    The DSO Hygienist with Christine Diehl — The Business of Brighter Smiles Making Teeth Whitening Work for Your Practice · Nov 2026

  • MixedGuest is cautious about new analgesic claims without rigorous evidence ('a really hard line for me to cross'), yet enthusiastic about adding maropitant to standard protocols and using a broader toolbox including cannabinoids and…

    The Cone of Shame Veterinary Podcast — 424 - Does Maropitant Really Reduce Surgical Pain? · Oct 2026

  • SkepticalGuest is wary of 'brand new shiny things' and 'the noise,' urging 'stick to the system because it works' over DIY changes, though she did make a major personal shift from pharmacy to chiropractic and a cash-based model.

    The Family Practice Podcast — 120. Kids and Families Will Come. You Just Have to Have the Courage to Say It. · Oct 2026

Index Trend — Health & Life Sciences

Future OutlookEconomyAI
30405060708090Dec '23Aug '25Oct '25Dec '25Feb '26Apr '26Jun '26Aug '26Oct '26Nov '26

Gaps in a line are months where this segment fell below the minimum sample threshold.